| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association of Sarcopenia With Toxicity and Survival in Patients With Lung Cancer, a Multi-Institutional Study With External Dataset Validation
|
Saraf, Anurag
|
|
|
26 |
4 |
p. e249-e258.e10
|
artikel
|
| 2 |
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)
|
García-Pardo, Miguel
|
|
|
26 |
4 |
p. e300-e305.e2
|
artikel
|
| 3 |
Comparative Effectiveness of Nivolumab and Ipilimumab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in PD-L1 Negative Metastatic Non-Small Cell Lung Cancer Patients
|
Verschueren, Marjon V.
|
|
|
26 |
4 |
p. e243-e248.e1
|
artikel
|
| 4 |
Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation Immunotherapy: A Cohort Study
|
Wallace, Neil D
|
|
|
26 |
4 |
p. e311-e320.e6
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
26 |
4 |
p. A1
|
artikel
|
| 6 |
First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYP GFPC 05-2018)
|
Corre, Romain
|
|
|
26 |
4 |
p. 331-337
|
artikel
|
| 7 |
Genomic Profiling of Driver Gene Alterations in Patients With Non–Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Center Experience of More Than 1200 Patients
|
Shah, Minit
|
|
|
26 |
4 |
p. e270-e283
|
artikel
|
| 8 |
Induction Immunochemotherapy Followed by Hypo-Fractionated Radiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer
|
Zhu, Zihao
|
|
|
26 |
4 |
p. 279-287.e4
|
artikel
|
| 9 |
Longitudinal Analysis of Recurrence and Risk Factors of Early-Stage Resected Adenocarcinoma With Common EGFR Mutations: A Multicenter Retrospective Cohort Study in South Korea
|
Ahn, June Hong
|
|
|
26 |
4 |
p. 314-323.e6
|
artikel
|
| 10 |
Nonbacterial Thrombotic Endocarditis (NBTE) Treated With Crizotinib in Lung Adenocarcinoma Harboring ROS-1 Rearrangement: Two Case Report and Review of Literature
|
Chamorro-Pérez, Jesús
|
|
|
26 |
4 |
p. e293-e299
|
artikel
|
| 11 |
Outcomes of Segmentectomy With or Without Preoperative Biopsy in Non-Small Cell Lung Cancer (NSCLC)
|
Alaparthi, Sneha S.
|
|
|
26 |
4 |
p. 299-306
|
artikel
|
| 12 |
Patients With Advanced Non–small Cell Lung Cancer Harboring MET Alterations: A Descriptive Cohort Study
|
Oksen, Dina
|
|
|
26 |
4 |
p. e259-e269.e5
|
artikel
|
| 13 |
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System Disease
|
Lu, Chang
|
|
|
26 |
4 |
p. 263-266
|
artikel
|
| 14 |
Predictors of Up-To-Date Lung Cancer Screening Among Eligible People in the United States: A Nationally Representative Dataset
|
Elkefi, Safa
|
|
|
26 |
4 |
p. 271-278
|
artikel
|
| 15 |
Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers
|
Gutta, Radhika
|
|
|
26 |
4 |
p. 307-313.e7
|
artikel
|
| 16 |
Small Cell Lung Cancer With de novo BRAF V600E Mutation and Durable Response to Targeted Therapy: A Case Report
|
Kulkarni, Radhika
|
|
|
26 |
4 |
p. e306-e310
|
artikel
|
| 17 |
Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and Analysis of Demographic, Clinical and Molecular Characteristics
|
Trisolini, Rocco
|
|
|
26 |
4 |
p. e284-e292
|
artikel
|
| 18 |
Table of Contents
|
|
|
|
26 |
4 |
p. A3-A6
|
artikel
|
| 19 |
Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series
|
Le, Xiuning
|
|
|
26 |
4 |
p. 338-346.e1
|
artikel
|
| 20 |
The PESGA Trial: A Prospective, Open-Label, Single-Arm, Phase II Study to Evaluate First Line Therapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Patients, Treated by Induction Carboplatin/Etoposide/Pembrolizumab Followed by Maintenance of Pembrolizumab/ Sacituzumab Govitecan
|
Roisman, Laila C.
|
|
|
26 |
4 |
p. 267-270
|
artikel
|
| 21 |
The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study
|
Kicken, Mart P.
|
|
|
26 |
4 |
p. 324-330.e3
|
artikel
|
| 22 |
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients
|
Barrichello, Adriana P.C.
|
|
|
26 |
4 |
p. 288-298.e8
|
artikel
|
Tijdschrift beschrijving